Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis
Author:
Publisher
Elsevier BV
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference18 articles.
1. Comment on “Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19”;Cure;J Med Virol,2020
2. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase;Vickers;J Biol Chem,2002
3. Liu W, Li H. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv Preprint. https://doi.org/10.26434/chemrxiv.11938173.v7.
4. Comment on ’Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade;Cure;Nephron,2020
5. Comment: sodium-glucose cotransporters as potential therapeutic targets in patients with type 1 diabetes mellitus: an update on phase 3 clinical trial data;Cumhur Cure;Ann Pharmacother,2020
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19;Endocrine;2024-03-06
2. A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes;The American Journal of Medicine;2024-03
3. Association of common variant rs9934336 of SLC5A2 (SGLT2) gene with SARS-CoV-2 infection and mortality;Egyptian Journal of Medical Human Genetics;2024-01-24
4. SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?;Journal of Cardiovascular Development and Disease;2023-11-29
5. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention;Frontiers in Immunology;2023-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3